Drug/Insect/Latex News

The allergy and immunology community has achieved significant and hopeful progress in its understanding of allergic reactions to mRNA COVID-19 vaccines, according to a review published in The Journal of Allergy and Clinical Immunology.

Dental implant failures were more common among patients who reported a penicillin allergy and received other antibiotics than those who used amoxicillin, according to a study published in Clinical Implant Dentistry and Related Research.

None of the patients with a penicillin allergy label who received cefazolin before surgery experienced allergic symptoms related to the antibiotic, according to a study published in Annals of Allergy, Asthma & Immunology.

As Healio celebrates National Doctors' Day today, we recognize dedicated physicians we spoke with over the past year about how they are working both in the clinic and beyond to improve allergy, asthma and immunology care.

The risk for anaphylaxis from IV iron formulations appeared low, although it varied depending on the type of treatment being administered, according to a study published in Annals of Internal Medicine.

An examination of the health records of more than 330,000 children in two large pediatric primary care networks has raised concerns about the validity of penicillin allergy labels, according to a study published in JAMA Network Open.

Antibiotic allergy labels appeared strongly associated with disease burden but not with hospital length of stay, according to a study published in Annals of Allergy, Asthma & Immunology.

PHOENIX — Factors considered high risk for penicillin allergy should not preclude children from undergoing reevaluation, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Patients with alpha-gal syndrome reported many physical and mental effects along with a profound quality-of-life impact, according to survey results presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Anaphylaxis accounted for 15% of the adverse reports from clinicians after mRNA vaccinations for COVID-19, according to a late-breaking abstract at the American Academy of Allergy, Asthma & Immunology Annual Meeting.